bioRxiv Science⌕ Search

Biology subjects

Pham, A. D.

Publications and source records attributed to Pham, A. D..

2 recordsLinked to original sources

The influence of heteroresistance, growth and antibiotic selection in shaping the invasion dynamics of colistin resistant Pseudomonas aeruginosa

Heteroresistance, where a small subpopulation of phenotypically resistant cells coexists within an otherwise susceptible population, plays a critical role in bacterial survival during antibiotic exposure. Yet, its influence on the invasion success of genetically resistant strains remains poorly understood. In this study, we investigate the influence of bacterial heteroresistance, growth, and antibiotic selection on the outcome of an invasion experiment. We quantified the invasion dynamics of a bioluminescent colistin-resistant Pseudomonas aeruginosa strain across a colistin concentration gradient during co-culture with colistin-susceptible clinical P. aeruginosa isolates with varying levels of heteroresistance. The observed variation in heteroresistance and fitness of the clinical isolates allowed investigation of the impact of these factors on invasion dynamics. We hypothesized that fitter isolates would limit invasion through competitive exclusion, while heteroresistant isolates, despite their growth costs, may serve as reservoirs for resistance evolution under antibiotic selection. Our results show that in antibiotic-free conditions, faster-growing isolates competitively excluded the colistin resistant invader while isolates with high levels of heteroresistance failed to do so. This competitive landscape shifted with increasing colistin concentration, giving the invader a fitness advantage that peaked around 2-4xMIC of the clinical isolate. The shift in the landscape over the colistin gradient might further have been influenced by the presence of heteroresistance in the clinical isolates. These findings reveal how both heteroresistance and competitive exclusion shapes invasion dynamics. Understanding these interactions is critical for redesigning treatment strategies that minimize ecological opportunities for resistant strains to establish and expand.

microbiology↗

β-nicotinamide mononucleotide production in Vibrio natriegens: a preliminary study

BackgroundNicotinamide mononucleotide (NMN), is a promising nutraceutical attracting much attention for its pharmacological and anti-aging efficacies. However, NMN-containing commercial products are very high-priced due to the lack of efficient and facile methods for industrial-scale production. To date, various metabolic engineering strategies have been successfully applied to produce NMN in Escherichia coli. Recently, Vibrio natriegens has become a promising host in the bioindustry thanks to its rapid growth and capabilities of broad substrate utilization. This study aims to evaluate the NMN biosynthesis capability of V. natriegens. MethodsFirstly, a mutant V. natriegens strain ({Delta}dns::araC-T7RNAP-KanR{Delta} pncC::FtnadE-SmR{Delta} nadR) was generated via multiplex genome editing by natural transformation (MuGENT). Nampt genes encoding nicotinamide phosphoribosyltransferase from Chitinophaga pinensis, Sphingopyxis sp. C-1, Haemophilus ducreyi, and Vibrio phage KVP40 were codon-optimized and cloned into pACYCDuet-1 under the control of T7 promoter. The recombinant plasmids were electroporated into the mutant strain. The expression of recombinant NAMPTs in V. natriegens was evaluated by SDS-PAGE analysis and the intracellular NMN concentrations were quantified by HPLC. ResultsAfter two rounds of MuGENT, V. natriegens V54-33 strain ({Delta}dns::araC-T7RNAP-KanR{Delta} pncC::FtnadE-SmR{Delta} nadR) was successfully generated. SDS-PAGE analysis demonstrated that all NAMPTs were strongly expressed in the V54-33 strain. HPLC analysis revealed that the highest intracellular NMN concentration was obtained with NAMPT from Chitinophaga pinensis (44.5 M), followed by NAMPT from Vibrio phage KVP40 (23.3 M). ConclusionThis study demonstrated the feasibility of NMN biosynthesis in V. natriegens.

bioengineering↗